This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lg Chem, Ltd. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Hye Won Ahn - Innovator in Pharmaceutical Research
Introduction
Hye Won Ahn is a talented inventor based in Seoul, South Korea. She is currently employed at LG Chem, Ltd., a leading company in the chemical and pharmaceutical industry. Although she has not yet been granted any patents, her work focuses on significant advancements in the field of pharmaceuticals.
Latest Patent Applications
Hye Won Ahn has been involved in several notable patent applications. One of her latest applications is for a compound that acts as a melanocortin-4 receptor agonist. This invention relates to a compound demonstrating excellent agonistic activity for the melanocortin receptor. Specifically, it includes a pharmaceutical composition containing this compound as an active ingredient, which can be used for preventing or treating conditions such as obesity, diabetes, inflammation, and impotence. Another application focuses on the uses of this compound for preventing or treating rare genetic obesity diseases, particularly those associated with a damaged melanocortin-4 receptor (MC4R) pathway.
Conclusion
Hye Won Ahn is making strides in pharmaceutical research, particularly in the area of melanocortin-4 receptor agonists. Her innovative work has the potential to contribute significantly to the treatment of various health conditions.